CLOS
NVO

Compagnie Lombard Odier SCmA’s Novo Nordisk NVO Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$764K Sell
20,780
-24,380
-54% -$1.16M 0.01% 175
2025
Q4 		$2.3M Sell
45,160
-675
-1% -$34.5K 0.03% 120
2025
Q3 		$2.54M Sell
45,835
-5,250
-10% -$307K 0.03% 121
2025
Q2 		$3.53M Sell
51,085
-12,145
-19% -$826K 0.05% 105
2025
Q1 		$4.39M Sell
63,230
-4,515
-7% -$373K 0.05% 108
2024
Q4 		$5.83M Buy
67,745
+3,200
+5% +$346K 0.09% 93
2024
Q3 		$7.69M Buy
64,545
+800
+1% +$107K 0.12% 83
2024
Q2 		$9.1M Sell
63,745
-85
-0.1% -$11.3K 0.15% 76
2024
Q1 		$8.2M Buy
63,830
+7,255
+13% +$864K 0.15% 88
2023
Q4 		$5.85M Buy
56,575
+8,665
+18% +$857K 0.11% 96
2023
Q3 		$4.36M Buy
47,910
+1,400
+3% +$123K 0.1% 98
2023
Q2 		$3.76M Buy
46,510
+22,010
+90% +$1.8M 0.11% 87
2023
Q1 		$1.95M Buy
24,500
+12,982
+113% +$921K 0.05% 130
2022
Q4 		$780K Sell
11,518
-1,200
-9% -$70.4K 0.02% 165
2022
Q3 		$634K Buy
+12,718
New +$681K 0.02% 194
2018
Q1 		– Sell
-200
Closed -$6K – 641
2017
Q4 		$6K Sell
200
-45,600
-100% -$1.16M ﹤0.01% 616
2017
Q3 		$1.1M Hold
45,800
– – 0.04% 206
2017
Q2 		$982K Sell
45,800
-2,800
-6% -$56.5K 0.03% 221
2017
Q1 		$833K Buy
+48,600
New +$846K 0.03% 233

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Compagnie Lombard Odier SCmA's NVO Position: Q1 2026 in Review

Compagnie Lombard Odier SCmA reduced its Novo Nordisk (NVO) stake by 54% in Q1 2026, selling an estimated $1.16M and leaving 20,780 shares worth $764K. The position accounts for 0.01% of the portfolio, ranked #175.

Compagnie Lombard Odier SCmA first reported a position in NVO in Q1 2017 and has held it in 19 quarters since. The position peaked at $9.1M in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Compagnie Lombard Odier SCmA held 20,780 shares of Novo Nordisk worth $764K as of Q1 2026.
  • Compagnie Lombard Odier SCmA sold 24,380 Novo Nordisk shares in Q1 2026, an estimated $1.16M.
  • Novo Nordisk made up 0.01% of Compagnie Lombard Odier SCmA's portfolio in Q1 2026, its #175 holding.
  • Compagnie Lombard Odier SCmA first reported a position in Novo Nordisk in Q1 2017 and has held it in 19 quarters since.
  • Compagnie Lombard Odier SCmA's Novo Nordisk position peaked at $9.1M in Q2 2024.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q1 2026, filed 15 Apr 2026.